Limitations
muscle soreness
The present trial has potential limitations. First, muscle soreness with VAS as the primary outcome was significantly lower in the active group than in the placebo group immediately after the exercise load. At this point, the power was 0.60 and the sample size for 0.8 of power was 28. Second, despite targeting middle-aged individuals, only males were selected as study participants due to sex-related differences in fitness.